Company Name
Aerovate Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN:
US0080641071
CIK:
0001798749
CUSIP:
008064107
Currency:
USD
Full Time Employees:
4
Phone:
617 443 2400
Website:
https://www.aerovatetx.com
Fiscal Year End:
December
IPO Date:
Jun 30, 2021
Description:
Aerovate Therapeutics, Inc., a biopharmaceutical company, engages in the treatment of pulmonary arterial hypertension in the United States. Aerovate Therapeutics, Inc., was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
Address:
930 Winter Street, Waltham, MA, United States, 02451